The opinion magazine of the American Gastroenterological Association
Most Crohn’s disease patients who undergo an intestinal resection will have postoperative recurrence. The most effective way to prevent recurrence is to initiate an anti-TNF within four weeks of surgery. It has been my practice that patients at high risk for postoperative Crohn’s disease recurrence initiate anti-TNF shortly after they are discharged from the hospital. […]
A surgical resection for a patient with Crohn’s disease is a major milestone in the natural history of their condition. It is without a doubt that patients who require surgery will make avoiding further surgery a priority and accordingly many patients will consider any possible preventive measure. I explain to patients that surgery is usually […]
Robert “Bob” Funderburg was well-known in Rockford, IL, and throughout the state as a successful businessman and philanthropist. Both Bob and his wife, Sally, were active in many charitable causes in Rockford and Chicago, particularly focusing their efforts in the areas of health care, the arts and education. In the spring of 1990, Bob’s life […]
“Faster” is the new normative way of living and the demand for instant results affects every aspect of our lives. We want instant access to movies that can be streamed from our devices. We want our shopping purchases to be shipped to our door on the same day. We want the most reliable and accurate […]
The advent of direct acting antivirals (DAAs) in the treatment of chronic hepatitis C infection has been revolutionary in that they have drastically mitigated the side effects of therapy while enhancing efficacy relative to interferon-based therapy. DAAs are broadly categorized into the NS3/4A protease inhibitors, NS5A inhibitors, and the non-nucleoside and nucleotide NS5B inhibitors. Ribavirin, […]
Additional contributors to this article: Jon Sanders, PHD, Anupriya Tripathi, Qiyun Zhu, Phd. The American Gut Project1 is the country’s largest open source crowd-funded citizen science project in existence today. As of early 2017, the project has raised over $2 million and processed over 14,000 samples from over 10,000 individuals (and counting). Over the last […]
This commentary describes the current status of the multi-target stool DNA test (mt-sDNA) (Cologuard®, Exact Sciences, Madison, WI) and of stool-based markers for GI diseases. Approved by both the U.S. Food and Drug Administration and the Center for Medicare and Medicaid Services in August 2014, the mt-sDNA test is a non-invasive screening test for colorectal […]
Most Crohn’s disease patients who undergo an intestinal resection will have postoperative recurrence. The most effective way to prevent recurrence is to initiate an anti-TNF within four weeks of surgery. It has been my practice that patients at high risk for postoperative Crohn’s disease recurrence initiate anti-TNF shortly after they are discharged from the hospital. […]
A surgical resection for a patient with Crohn’s disease is a major milestone in the natural history of their condition. It is without a doubt that patients who require surgery will make avoiding further surgery a priority and accordingly many patients will consider any possible preventive measure. I explain to patients that surgery is usually […]
The mission of the AGA Institute Research Policy Committee (RPC) is to promote basic and clinical research in gastroenterology and hepatology. Over the last year, the RPC has engaged in several activities to further this mission. First, the RPC offered the AGA Institute Governing Board formal recommendations regarding prioritization and allocation of AGA’s endowment for […]
Stay Connected